MGC Pharmaceuticals Buy Hold or Sell Recommendation

MGCLFDelisted Stock  USD 0.21  0.00  0.00%   
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding MGC Pharmaceuticals is 'Not Rated'. Macroaxis provides MGC Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MGCLF positions.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Note, we conduct extensive research on individual companies such as MGC and provide practical buy, sell, or hold advice based on investors' constraints. MGC Pharmaceuticals. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Execute MGC Pharmaceuticals Buy or Sell Advice

The MGC recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MGC Pharmaceuticals. Macroaxis does not own or have any residual interests in MGC Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MGC Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell MGC PharmaceuticalsBuy MGC Pharmaceuticals
Not Rated
For the selected time horizon MGC Pharmaceuticals has a Risk Adjusted Performance of (0.08), Jensen Alpha of (0.30), Total Risk Alpha of (0.79) and Treynor Ratio of 0.4125
We provide trade recommendation to complement the latest expert consensus on MGC Pharmaceuticals. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available right now. To make sure MGC Pharmaceuticals is not overpriced, please verify all MGC Pharmaceuticals fundamentals, including its shares owned by insiders, ebitda, book value per share, as well as the relationship between the price to sales and total debt . As MGC Pharmaceuticals appears to be a penny stock we also strongly suggest to check its shares owned by institutions numbers.

MGC Pharmaceuticals Trading Alerts and Improvement Suggestions

MGC Pharmaceuticals is not yet fully synchronised with the market data
MGC Pharmaceuticals has some characteristics of a very speculative penny stock
MGC Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
MGC Pharmaceuticals has accumulated 4.35 M in total debt with debt to equity ratio (D/E) of 0.84, which is about average as compared to similar companies. MGC Pharmaceuticals has a current ratio of 0.82, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MGC Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, MGC Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MGC Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MGC to invest in growth at high rates of return. When we think about MGC Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 4.65 M. Net Loss for the year was (20.35 M) with profit before overhead, payroll, taxes, and interest of 562.87 K.
MGC Pharmaceuticals has accumulated about 1.89 M in cash with (12.16 M) of positive cash flow from operations.

MGC Pharmaceuticals Returns Distribution Density

The distribution of MGC Pharmaceuticals' historical returns is an attempt to chart the uncertainty of MGC Pharmaceuticals' future price movements. The chart of the probability distribution of MGC Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use MGC Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MGC Pharmaceuticals returns is essential to provide solid investment advice for MGC Pharmaceuticals.
Mean Return
-0.38
Value At Risk
-3.7
Potential Upside
0.00
Standard Deviation
3.26
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MGC Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

MGC Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MGC . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About MGC Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell MGC Pharmaceuticals? Buying financial instruments such as MGC OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having MGC Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials Thematic Idea Now

Financials
Financials Theme
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in MGC OTC Stock

If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios